ABBOTT PARK, Ill., Jan. 10, 2017
/PRNewswire/ -- Abbott (NYSE: ABT) announced today its
Alinity™ ci-series instruments for clinical chemistry and
immunoassay diagnostics have obtained CE Mark and are now available
in Europe and other countries that
recognize CE Mark. These innovative testing solutions help labs run
more tests in less time, reduce human error and increase testing
productivity.
"Better healthcare begins with a high performing lab. Abbott's
Alinity family is an unprecedented approach to providing a more
efficient, complete lab solution that no competitor in the industry
can match," said Brian Blaser,
executive vice president, Diagnostics Products, Abbott. "Abbott is
bringing meaningful innovation to diagnostic testing, elevating the
role it plays in improving clinical decision making and delivering
high quality care to patients."
Offering a flexible, modular design, the "Alinity c" clinical
chemistry system, and the "Alinity i" immunoassay system, can
operate individually or as an integrated Alinity ci-series unit,
all within half the size of current diagnostics systems.
"The Alinity ci has the potential to be a game-changer for our
lab, as it is designed to solve many of the issues that we face,"
said Mario Plebani, M.D., Professor
of clinical biochemistry and clinical molecular biology, School of
Medicine, University of Padova – Italy. "Every day we see greater demand for
tests with fewer resources. The new Alinity systems are easier to
use, helping to prevent errors and increase staff efficiency."
In addition to greater capacity in a smaller footprint, the
Alinity ci-series maintains the high quality performance of
Abbott's current systems and has a number of new features based
upon customer insights. Features include:
- Increased loading capacity for samples and tests, and separate
lanes to run urgent tests without interrupting lab workflow.
- Continuous access to solutions and supplies, which gives labs
the ability to reload solutions without pausing or stopping
instruments or testing cycles for prolonged periods of time.
- Solution bottles designed to work like a lock and key to ensure
the right solutions can only be inserted into the right
location.
- Intuitive menu design and user-friendly interface, common to
the Alinity family of instruments, which simplifies training for
lab technicians.
"To design the Alinity ci Systems, we spent countless hours with
our customers in the design phase to ensure that we built a
solution for the issues they face every day–including higher
testing volumes, a lack of staffing and space, and complex,
time-intensive processes and instruments," said Dennis Gilbert, Ph.D., vice president, research
and development, Diagnostics, Abbott. "The Alinity family of
systems simplifies diagnostic testing while delivering results that
drive better patient outcomes."
Abbott will launch clinical chemistry and immunoassay tests for
the Alinity ci-series in phases, with a complete menu of tests
available within a year of launch.* Clinical chemistry tests detect
the presence of different chemicals in the blood and include tests
such as sodium, potassium, glucose and calcium. Immunoassay methods
use antibody or antigen recognition to detect complex molecules and
provide information related to infectious diseases, hormone levels,
cardiac risk factors, cancer, thyroid issues and therapeutic
drugs.
About Alinity
Abbott's Alinity family of harmonized
solutions is unprecedented in the diagnostics industry, working
together to address the challenges of using multiple diagnostics
platforms and simplify diagnostic testing. Alinity systems are
designed to be more efficient – running more tests in less space,
generating test results faster and minimizing human errors – while
continuing to provide quality results.
The Alinity portfolio includes clinical chemistry, immunoassay,
blood and plasma screening, point of care, hematology and molecular
diagnostics, along with Abbott's AlinIQ—a first-of-its-kind,
holistic suite of professional services that combines expertise
with process analysis and informatics. Alinity is helping labs and
hospital systems solve some of their most pressing challenges to
deliver better patient care with fewer resources. More information
is available at abbott.com/alinity.
About Abbott:
At Abbott, we're committed to helping
you live your best possible life through the power of health. For
more than 125 years, we've brought new products and technologies to
the world -- in nutrition, diagnostics, medical devices and branded
generic pharmaceuticals -- that create more possibilities for more
people at all stages of life. Today, 74,000 of us are working to
help people live not just longer, but better, in the more than 150
countries we serve.
Connect with us at www.abbott.com, on Facebook at
www.facebook.com/Abbott and on Twitter @AbbottNews and
@AbbottGlobal.
*Note: Local product availability may vary depending on
geographic location.
______________________________
1 Abbott Alinity ci Systems Operations Manual.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abbott-announces-ce-mark-for-its-alinity-ci-series-diagnostic-systems-300388278.html
SOURCE Abbott